FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
暂时没有全文，请查看原始来源。
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death